Login / Signup

Evaluation of the safety and effectiveness of intradermal administration of QR678 Neo ® hair growth factor formulation: A phase-IV, open-label, single-arm multi-ethnicity clinical trial.

Aayna ClinicAnnette AsperApoorva MittalDebraj ShomeDeepa ParbhooJames ThanzamaKomal DoshiNeha SachdeRidhima GaunkarRinky KapoorRukshmani ThakkarSimal SionSushant ShettyVaibhav KumarVeena ParveenVivek Singhal
Published in: Journal of cosmetic dermatology (2022)
is an innovative, efficacious, and safe technique for the treatment of androgenetic alopecia and female pattern hair loss.
Keyphrases
  • growth factor
  • clinical trial
  • open label
  • phase ii
  • randomized controlled trial
  • study protocol
  • phase iii
  • systematic review
  • drug delivery
  • rectal cancer